Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

HPMA-RGD hydrogels seeded with mesenchymal stem cells improve functional outcome in chronic spinal cord injury

Aleš Hejčl, Jiří Šedý, Miroslava Kapcalová, David Arboleda Toro, Takashi Amemori, Petr Lesný, Katarina Likavčanová-Mašínová, Eva Krumbholcová, Martin Přádný, Jiří Michálek, Martin Burian, Milan Hájek, Pavla Jendelová, Eva Syková

. 2010 ; 19 (10) : 1535-1546.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc14067271

Grantová podpora
1A8697 MZ0 CEP - Centrální evidence projektů

Chronic spinal cord injury (SCI) is characterized by tissue loss and a stable functional deficit. While several experimental therapies have proven to be partly successful for the treatment of acute SCI, treatment of chronic SCI is still challenging. We studied whether we can bridge a chronic spinal cord lesion by implantation of our newly developed hydrogel based on 2-hydroxypropyl methacrylamide, either alone or seeded with mesenchymal stem cells (MSCs), and whether this treatment leads to functional improvement. A balloon-induced compression lesion was performed in adult 2-month-old male Wistar rats. Five weeks after injury, HPMA-RGD hydrogels [N-(2-hydroxypropyl)-methacrylamide with attached amino acid sequences--Arg-Gly-Asp] were implanted into the lesion, either with or without seeded MSCs. Animals with chronic SCI served as controls. The animals were behaviorally tested using the Basso-Beattie-Breshnahan (BBB) (motor) and plantar (sensory) tests once a week for 6 months. Behavioral analysis showed a statistically significant improvement in rats with combined treatment, hydrogel and MSCs, compared with the control group (P < 0.05). Although a tendency toward improvement was found in rats treated with hydrogel only, this was not significant. Subsequently, the animals were sacrificed 6 months after SCI, and the spinal cord lesions evaluated histologically. The combined therapy (hydrogel with MSCs) prevented tissue atrophy (P < 0.05), and the hydrogels were infiltrated with axons myelinated with Schwann cells. Blood vessels and astrocytes also grew inside the implant. MSCs were present in the hydrogels even 5 months after implantation. We conclude that 5 weeks after injury, HPMA-RGD hydrogels seeded with MSCs can successfully bridge a spinal cord cavity and provide a scaffold for tissue regeneration. This treatment leads to functional improvement even in chronic SCI.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc14067271
003      
CZ-PrNML
005      
20140807150303.0
007      
ta
008      
140807s2010 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1089/scd.2009.0378 $2 doi
035    __
$a (PubMed)20053128
040    __
$a ABA008 $d ABA008 $e AACR2 $b cze
041    0_
$a eng
044    __
$a xxu
100    1_
$a Hejčl, Aleš, $d 1978- $7 xx0077402 $u Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Prague, Czech Republic; Department of Neuroscience and Centre for Cell Therapy and Tissue Repair, Charles University, Prague, Czech Republic; Department of Neurosurgery, Masaryk Hospital, Ústí nad Labem, Czech Republic
245    10
$a HPMA-RGD hydrogels seeded with mesenchymal stem cells improve functional outcome in chronic spinal cord injury / $c Aleš Hejčl, Jiří Šedý, Miroslava Kapcalová, David Arboleda Toro, Takashi Amemori, Petr Lesný, Katarina Likavčanová-Mašínová, Eva Krumbholcová, Martin Přádný, Jiří Michálek, Martin Burian, Milan Hájek, Pavla Jendelová, Eva Syková
520    9_
$a Chronic spinal cord injury (SCI) is characterized by tissue loss and a stable functional deficit. While several experimental therapies have proven to be partly successful for the treatment of acute SCI, treatment of chronic SCI is still challenging. We studied whether we can bridge a chronic spinal cord lesion by implantation of our newly developed hydrogel based on 2-hydroxypropyl methacrylamide, either alone or seeded with mesenchymal stem cells (MSCs), and whether this treatment leads to functional improvement. A balloon-induced compression lesion was performed in adult 2-month-old male Wistar rats. Five weeks after injury, HPMA-RGD hydrogels [N-(2-hydroxypropyl)-methacrylamide with attached amino acid sequences--Arg-Gly-Asp] were implanted into the lesion, either with or without seeded MSCs. Animals with chronic SCI served as controls. The animals were behaviorally tested using the Basso-Beattie-Breshnahan (BBB) (motor) and plantar (sensory) tests once a week for 6 months. Behavioral analysis showed a statistically significant improvement in rats with combined treatment, hydrogel and MSCs, compared with the control group (P < 0.05). Although a tendency toward improvement was found in rats treated with hydrogel only, this was not significant. Subsequently, the animals were sacrificed 6 months after SCI, and the spinal cord lesions evaluated histologically. The combined therapy (hydrogel with MSCs) prevented tissue atrophy (P < 0.05), and the hydrogels were infiltrated with axons myelinated with Schwann cells. Blood vessels and astrocytes also grew inside the implant. MSCs were present in the hydrogels even 5 months after implantation. We conclude that 5 weeks after injury, HPMA-RGD hydrogels seeded with MSCs can successfully bridge a spinal cord cavity and provide a scaffold for tissue regeneration. This treatment leads to functional improvement even in chronic SCI.
590    __
$a bohemika - dle Pubmed
650    02
$a zvířata $7 D000818
650    02
$a chování zvířat $x fyziologie $7 D001522
650    02
$a chronická nemoc $7 D002908
650    02
$a lidé $7 D006801
650    12
$a hydrogely $x chemie $7 D020100
650    02
$a experimentální implantáty $7 D020007
650    02
$a mužské pohlaví $7 D008297
650    12
$a transplantace mezenchymálních kmenových buněk $7 D045164
650    02
$a mezenchymální kmenové buňky $x cytologie $x fyziologie $7 D059630
650    12
$a mezenchymální kmenové buňky $7 D059630
650    12
$a methakryláty $x chemie $7 D008689
650    12
$a regenerace nervu $x fyziologie $7 D009416
650    12
$a oligopeptidy $x chemie $7 D009842
650    02
$a náhodné rozdělení $7 D011897
650    02
$a krysa rodu Rattus $7 D051381
650    02
$a potkani Wistar $7 D017208
650    02
$a mícha $x patologie $7 D013116
650    02
$a poranění míchy $x patologie $x terapie $7 D013119
650    02
$a výsledek terapie $7 D016896
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Šedý, Jiří, $d 1980- $7 mzk2007411473 $u Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Prague, Czech Republic; Department of Neuroscience and Centre for Cell Therapy and Tissue Repair, Charles University, Prague, Czech Republic
700    1_
$a Kapcalová, M. $7 _AN046555 $u Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Prague, Czech Republic; Department of Neuroscience and Centre for Cell Therapy and Tissue Repair, Charles University, Prague, Czech Republic
700    1_
$a Toro, David Arboleda $u Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Prague, Czech Republic; Department of Neuroscience and Centre for Cell Therapy and Tissue Repair, Charles University, Prague, Czech Republic
700    1_
$a Amemori, Takashi, $d 1955- $7 xx0125986 $u Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Prague, Czech Republic; Department of Neuroscience and Centre for Cell Therapy and Tissue Repair, Charles University, Prague, Czech Republic
700    1_
$a Lesný, Petr, $d 1972- $7 xx0060590 $u Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Prague, Czech Republic; Department of Neuroscience and Centre for Cell Therapy and Tissue Repair, Charles University, Prague, Czech Republic
700    1_
$a Likavčanová, Katarína $7 _AN049556 $u Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Prague, Czech Republic; Department of Neuroscience and Centre for Cell Therapy and Tissue Repair, Charles University, Prague, Czech Republic
700    1_
$a Krumbholcová, Eva $7 _AN061377 $u Department of Neuroscience and Centre for Cell Therapy and Tissue Repair, Charles University, Prague, Czech Republic; Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Prague, Czech Republic
700    1_
$a Přádný, Martin $7 xx0149477 $u Department of Neuroscience and Centre for Cell Therapy and Tissue Repair, Charles University, Prague, Czech Republic; Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Prague, Czech Republic
700    1_
$a Michálek, Jiří $7 xx0149478 $u Department of Neuroscience and Centre for Cell Therapy and Tissue Repair, Charles University, Prague, Czech Republic; Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Prague, Czech Republic
700    1_
$a Burian, Martin $7 xx0148610 $u Department of Neuroscience and Centre for Cell Therapy and Tissue Repair, Charles University, Prague, Czech Republic; Institute for Clinical and Experimental Medicine, MRI Unit, Prague, Czech Republic
700    1_
$a Hájek, Milan, $d 1947- $7 xx0074172 $u Department of Neuroscience and Centre for Cell Therapy and Tissue Repair, Charles University, Prague, Czech Republic; Institute for Clinical and Experimental Medicine, MRI Unit, Prague, Czech Republic
700    1_
$a Jendelová, Pavla, $d 1965- $7 xx0068971 $u Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Prague, Czech Republic; Department of Neuroscience and Centre for Cell Therapy and Tissue Repair, Charles University, Prague, Czech Republic
700    1_
$a Syková, Eva, $d 1944- $7 jn20000710633 $u Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Prague, Czech Republic; Department of Neuroscience and Centre for Cell Therapy and Tissue Repair, Charles University, Prague, Czech Republic
773    0_
$t Stem cells and development $x 1547-3287 $g Roč. 19, č. 10 (2010), s. 1535-1546 $w MED00162608
910    __
$a ABA008 $y 4 $z 0
990    __
$a 20140807135018 $b ABA008
991    __
$a 20140807150627 $b ABA008
999    __
$a ok $b bmc $g 1034896 $s 866076
BAS    __
$a 3
BMC    __
$a 2010 $b 19 $c 10 $d 1535-1546 $i 1547-3287 $m Stem cells and development $x MED00162608 $n Stem Cells Dev
GRA    __
$a 1A8697 $p MZ0
LZP    __
$a 2014-08/abbo

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...